Over the past thirty years, research on Kinetic Hydrate Inhibitors (KHIs) has garnered widespread attention[
29,
30,
31,
32]. Compared to thermodynamic inhibitors, KHIs are favored for their lower dosage, reduced cost, environmental friendliness, and high inhibition efficiency. KHIs are primarily water-soluble polymers that delay nucleation by slowing or preventing the growth of hydrate crystals[
33]. They adsorb onto the surface of hydrate particles and form hydrogen bonds, thereby delaying crystal growth. Small amounts of KHIs can alter the growth characteristics of structure II hydrates, while for structure I hydrates, they trigger rapid branching phenomena[
34,
35,
36]. In summary, due to their low dosage, reduced cost, and environmental friendliness, KHIs have become an effective means of preventing and delaying hydrate formation. They significantly impact the nucleation and growth processes of hydrates, particularly in altering growth characteristics and controlling crystal branching.
Common kinetic inhibitors include polyvinylpyrrolidone (PVP) and polyvinylcaprolactam (PVCap)[
37,
38]. As shown in
Table 1 and
Figure 4, research on kinetic inhibitors can be divided into three stages: the first generation (1991-1995), the second generation (1995-1999), and the third generation (1999 to present). The first-generation kinetic inhibitors, primarily PVP, were selected through experimental evaluation[
39]. The second-generation inhibitors were improved based on the molecular structure of PVP through structure-activity relationship analysis and molecular design, with representative compounds including PVCap[
40]. The third-generation inhibitors have been developed through computer molecular simulation and design techniques, resulting in new compounds with better inhibition effects[
41]. Research and development in this field have progressed from basic screening to molecular design, continuously advancing and innovating to develop more efficient and environmentally friendly inhibitors to control hydrate formation.
2.1. First-Generation Kinetic Inhibitors
Since 1991, research on kinetic inhibitors has progressively deepened. Initially, researchers utilized alkyl aryl sulfonates and their salts as kinetic inhibitors[
42]. In 1993, researchers proposed using tyrosine and its derivatives, along with vinyl-containing polymers and complexing agents, as hydrate inhibitors[
43]. In 1994, polyvinylpyrrolidone (PVP) was discovered to delay hydrate formation. In the same year, hydroxyethyl cellulose (HEC) demonstrated similar effects, but PVP proved more effective[
44]. By 1995, experiments confirmed several effective chemical additives, including PVP, BASF F-127, Mirawet ASC, Surfynol-465, sodium dodecyl sulfate (SDS), Mirataine CBS+PVP, and SDS+PVP[
24]. Among these inhibitors, PVP is the most representative, with a relative molecular mass ranging from 10,000 to 350,000. Its monomer structure contains a five-membered lactam ring[
45,
46], as shown in
Figure 5.
The effectiveness of PVP lies in its structural characteristics, particularly the molecular weight range and the monomer structure of the five-membered lactam ring. It inhibits hydrate growth through hydrogen bonding and van der Waals forces, a mechanism validated by molecular simulations[
7]. Consequently, PVP has become a research focus due to its structural properties and its ability to prevent hydrate growth. This series of studies, by exploring the effects, testing, and molecular mechanisms of chemical additives, has revealed the potential and mechanisms of PVP and other inhibitors in preventing hydrate formation, representing progress and innovation in the field of hydrate formation control.
2.2. Second-Generation Kinetic Inhibitors
Although effective at relatively high temperatures, PVP performance under supercooling conditions around 5°C is limited and may even sometimes promote hydrate formation, highlighting the urgency of developing more effective kinetic hydrate inhibitors[
47]. The Gaffix VC-713 polymer, a terpolymer consisting of vinylcaprolactam (VCap), vinylpyrrolidone (VP), and dimethylaminoethyl methacrylate (DMAEMA), exhibits superior performance compared to PVP[
48], as shown in
Figure 6a. Specifically, the addition of PVCap or Gaffix VC-713 can significantly delay the nucleation process of hydrates. The structure of PVCap[
49], shown in
Figure 6b, and its copolymer with VP and VCap, Poly(VP-VC), shown in
Figure 6c, both exhibit good inhibition effects[
50]. Additionally, other polymers such as polyelectrolytes, polyethers, and polyvinylamines, used as co-inhibitors with PVCap, can further enhance performance through synergistic effects between the polymers. The VIMA-VCap copolymer, synthesized by RF Company, consists of N-methyl-N-vinylacetamide and VCap in a 1:1 ratio and outperforms PVCap[
51], with a supercooling enhancement of 2 to 3°C in sapphire cell tests. RF Company also synthesized and tested other VCap copolymers, including those with vinyl imidazole, all of which showed good effects. The structure of the VIMA-VCap copolymer is shown in
Figure 6d.
The inhibitory effects of PVCap, PVP, VC-713, and VP-VCap copolymers are closely related to system pressure, salinity, and inhibitor concentration, and are influenced by multiple factors[
52]. Experiments show that the inhibitory effect of the VP-VCap copolymer (molar ratio 25/75) is comparable to that of VC-713 or PVCap, confirming the copolymer’s effectiveness[
53]. Methanol and low salinity negatively affect PVCap’s performance, while high salinity (>5.5%) is beneficial, highlighting the significant role of salinity in inhibiting hydrate formation[
54]. The relative molecular mass of PVCap significantly impacts its performance, particularly when the molecular mass is 900[
55], demonstrating optimal supercooling and emphasizing the importance of molecular mass in inhibitor performance. PVCap’s interaction with hydrate solutions is more effective as a kinetic inhibitor compared to PVP. The performance of PVP can be enhanced through chemical modification by adding hydroxyl groups[
56], demonstrating the potential for optimizing inhibitor performance[
57]. VC-713 also exhibits good interaction with hydrate solutions. Low-dose inhibitors (PVP, PVCap, VC-713) significantly extend hydrate decomposition time, with PVCap showing the most pronounced effect, highlighting its superiority in inhibition[
58]. These findings are crucial for designing and selecting more effective hydrate inhibition methods, particularly noting PVCap’s superior performance in high salinity and the potential to enhance PVP performance through chemical modification.
PVCap are significant differences in inhibiting Type II and Type I hydrate structures[
49]. The supercooling of Type I hydrates is lower than that of Type II hydrates, which is closely related to the high symmetry of Type I hydrate crystals[
59,
60,
61,
62,
63]. Experiments have shown that under dynamic stirring conditions, compared to static solutions, the growth of hydrate crystals can be inhibited with a lower dose of kinetic hydrate inhibitors (KHIs), indicating higher inhibition efficiency under dynamic conditions[
64]. During shutdown periods, the required inhibitor dose under static conditions may be higher than under flowing conditions, which is crucial for designing hydrate inhibition strategies during shutdowns. Additionally, compared to high molecular-weight polymers, low molecular weight polymers perform better under static conditions due to their faster diffusion to the hydrate surface. Therefore, the performance of PVCap is influenced by the type of hydrate structure, the stirring state of the solution, and the molecular weight of the polymer[
40].
Exxon’s research indicates that the amide group plays a crucial role in kinetic hydrate inhibitor (KHI) polymers[
65,
66]. It promotes hydrate cavity formation through its connection with hydrophobic groups and inhibits hydrate nucleation by forming hydrogen bonds between the hydroxyl oxygen atom of the amide group and water molecules[
67]. Among various amide-containing polymers, including poly(diethylacrylamide), poly(isopropylacrylamide) (as shown in
Figure 7a and b), polyvinylamine, polypropylamine, and polymaleimide (as shown in
Figure 7c), acrylamide polymers exhibit the best KHI effects[
68]. Notably, poly(acryloylpyrrolidone), poly(diethylacrylamide), and poly(isopropylacrylamide) show the most outstanding performance[
69]. The research also points out that adding a methyl group to the main chain of acrylamide polymers can further enhance their performance[
70]. For instance, poly(isopropylmethacrylamide) (as shown in
Figure 7d) has a supercooling degree 2°C higher than that of poly(isopropylacrylamide)[
71]. This finding emphasizes the potential for improving polymer KHI performance through specific configurations of functional groups and optimization of chemical structures. Particularly for amide-containing acrylamide polymers, this indicates their high effectiveness in inhibiting hydrate nucleation. This research provides important guidance for designing and developing new, efficient KHIs, highlighting the importance of considering specific functional group roles and interactions in chemical structure design.
High-performance polyIPMA, particularly the type synthesized with butyl ethylene glycol, demonstrates significant competitive advantages over PVCap[
32]. These advantages are evident not only in its basic performance but also in the superior performance of hydroxy-terminated polyIPMA and polyIPMA with a bimodal molecular weight distribution in inhibiting hydrate formation compared to conventional polyIPMA.[
72,
73] Experiments have shown that as little as 0.5% of bimodal molecular weight distribution polyIPMA can significantly delay hydrate formation, achieving the highest supercooling performance to date (24.1°C supercooling, lasting up to 20 hours). The performance enhancement is closely related to the molecular weight, size, and activity of the samples. Notably, high molecular weight samples are more efficient in preventing hydrate nucleation and growth. Meanwhile, polyVIMA, a polyvinylamine polymer, has shown only weak kinetic inhibition properties. However, copolymers of VIMA with other alkylamine polymers, similar to the VIMA-VCap copolymer shown in
Figure 8, exhibit high supercooling performance, providing a new approach to enhancing hydrate inhibitor performance. In summary, specifically synthesized optimized polyIPMA polymers, such as the hydroxy-terminated version synthesized with butyl ethylene glycol and the version with a bimodal molecular weight distribution, have significant performance advantages in kinetically inhibiting hydrate formation. This emphasizes the potential of optimizing KHI performance by adjusting synthesis methods and molecular weight distribution. Additionally, the application of VIMA copolymers with other alkylamine polymers opens new pathways for improving the overall performance of hydrate inhibitors.
The VIMA-vinyl butyrate copolymer exhibited excellent anti-nucleation and crystal growth inhibition capabilities in high-pressure small-loop experiments[
74], outperforming PVCap, polyIPMAM, and polyAP, demonstrating its potential as a hydrate inhibitor. The butyrate group is considered a key factor, particularly effective in the VIMA-vinyl butyrate copolymer. Although the specific mechanism of interaction between ester and amine groups with the hydrate surface is not yet clear, it is hypothesized that hydrogen bonds formed by ester groups may be weaker than those formed by amine groups. In practical applications, polyvinylamide combined with quaternary compounds (such as TBAB) has performed well as a hydrate inhibitor (THI) and has been successfully applied in pipelines[
75]. Specifically, the combination of TPAB or TBAB with PVCap enhances the inhibitory effect, and molecular simulation studies indicate that TPAB can be embedded into the hydrate crystal surface, effectively preventing its growth[
53,
76,
77]. The KHI performance of polyAP is superior to Gaffix VC-713, especially when its molecular weight is in the range of 1000 to 3000. Although PVCap and PVP can be used as co-inhibitors with polyAP to enhance its performance, cost issues limit the widespread application of polyAP. Overall, the VIMA-vinyl butyrate copolymer stands out for its excellent hydrate inhibition performance, particularly due to its butyrate group, providing valuable direction for developing new, efficient hydrate inhibitors. The successful application of polyvinylamide and quaternary compound combinations has shown significant effects in hydrate inhibition, while polyAP and its combination with other polymers have shown potential for improving hydrate inhibition effects.
2.3. Third-Generation Kinetic Inhibitors
Molecular simulation technology is a vital tool for designing more effective low-dosage hydrate inhibitors (LDHIs), including kinetic hydrate inhibitors (KHIs) and anti-agglomerants (AAs)[
78]. This technology can identify functional groups that strongly interact with hydrate structure surfaces and integrate these groups into water-soluble polymers to create KHIs or embed them into surfactants to create AAs[
79]. RF Company’s molecular simulation studies have specifically found that alkylamine compounds containing 3 to 4 carbon atoms, particularly when the alkyl groups are branched structures like isopropyl and isobutyl, exhibit the strongest interactions with Type II hydrate surfaces, showing excellent inhibitory potential[
80]. Using polyisopropylacrylamides (polyIPA) as an example, this instance confirms the reliability of the molecular simulation results, although its inhibition effect is slightly lower than that of Gaffix VC-713 in actual tests.
Patent W001/77270 and Shell’s patent CN1685130A propose an innovative method using dendritic compounds as hydrate inhibitors[
81]. These dendritic compounds are three-dimensional, multi-branched oligomeric or polymeric molecules that include a core, multiple branching levels, and outer end groups. By combining at least one dendritic compound with a molecular mass of at least 1000 and at least one small molecular substance with a molecular mass of less than 1000 (such as polyalkylene imine, polyallylamine, etc.), along with a surfactant, a mixture capable of effectively inhibiting hydrate formation is formed. This mixture achieves synergistic control of hydrate formation through the inhibition of hydrate nucleation or crystal growth by the macromolecular and small molecular components and the surfactant’s function as a solvent or surface tension regulator. The small molecular substances can be further modified to include non-cyclic or cyclic side chain groups with heteroatoms such as N, O, or S. The surfactant can be cationic, anionic, or nonionic, such as polyoxyethylene ether or sorbitan. This method showcases an efficient hydrate inhibition strategy through the synergistic effect of the specific structural characteristics of the dendritic compounds, small molecular substances, and surfactants, effectively inhibiting the formation and growth of hydrates.
Dendritic compounds with high molecular weights, particularly polyamide ester types, demonstrate excellent performance in hydrate inhibition due to their unique non-cyclic or cyclic side chain groups containing N, O, or S heteroatoms[
82]. Notable examples include ASTRAMOL poly(propylene imine) dendrimers and HYBRANE hyperbranched polyamide esters. The main chains of these compounds, formed by the reaction of cyclic anhydrides with alkanol amines, feature hydrophobic amine groups similar to early kinetic inhibitors like PVCap and polyIPMA. The hydrophobic groups interact with the hydrate surface via van der Waals forces, while the amine groups form hydrogen bonds with water molecules, effectively preventing hydrate particle growth[
83]. Due to their highly branched structures, even polyamides with a molecular weight of around 1500 exhibit good KHI performance and bind more closely to the hydrate surface[
84]. Research by Baker Petrolite indicates that polyamide ester KHIs perform better in handling Type I hydrate structures formed under high methane content[
85]. Two field trials and subsequent field applications have demonstrated the effectiveness and application potential of these polymers in specific oil and gas field conditions. Overall, dendritic compounds with high molecular weights, especially polyamide esters, enhance interactions with hydrate surfaces due to their branched structures with specific side chain groups, showing particular suitability and effectiveness in inhibiting hydrate formation. These advances not only promote further research on hydrate inhibitors but also drive their field applications, particularly in handling high methane content Type I hydrate structures.
The patent filed by Kuraray Specialties Europe in 2002 demonstrates the effectiveness of polymers based on polyvinyl alcohol and its aldehyde reaction derivatives as kinetic hydrate inhibitors (KHIs)[
32], as shown in
Figure 9a–c, with particular emphasis on polymers containing acetal ester functional groups, where butyraldehyde is preferred. These polymers are suitable not only as KHIs but also as anti-agglomerants (AAs). Additionally, polyethylene oxide (PEO)[
86], as shown in
Figure 9d, has been proven to be an effective methane hydrate inhibitor, capable of quickly preventing hydrate formation at very low concentrations (0.1%) and significantly reducing the formation rate thereafter, outperforming pure water. Although hydroxyethyl cellulose (HEC), shown in
Figure 9e, and modified hydroxyethyl cellulose (HECE), shown in
Figure 9f, can slow down the hydrate formation rate[
87], their effects are weaker compared to polyvinylpyrrolidone (PVP). Particularly at a concentration of 1%, the inhibitory performance of PEO is more pronounced. In summary, polymers derived from polyvinyl alcohol and aldehyde reactions, especially those containing acetal ester functional groups, have been proven effective as hydrate inhibitors. PEO shows excellent inhibitory effects as a methane hydrate inhibitor at very low concentrations, while HEC and HECE, despite having inhibitory effects, are weaker in comparison.
In 2003, Akzo Nobel Company proposed a patent introducing a novel low-dosage hydrate inhibitor (LDHI) based on polyalkylene oxide amine[
88], marking a significant advancement in hydrate control technology. The production process of this inhibitor prefers alkylation with propylene oxide (PO), with triethanolamine as the amine of choice, although ammonia and other alkanol amines are also suitable. The patent specifically mentions the quaternary ammonium form of the amine, which shows promising potential in enhancing the inhibitory effect, particularly the quaternized product of triethanolamine containing 14.9 PO units (
Figure 10a), demonstrating the most significant effect. Experimental data indicate that without the addition of polyalkylene oxide amine, the initial temperature for hydrate formation is 5.6°C. However, with the addition of 1.0% polyalkylene oxide amine, the hydrate formation temperature significantly drops to 0.5°C[
89]. This demonstrates the effectiveness of polyalkylene oxide amine in reducing the hydrate formation temperature, and further enhancement of its performance as an LDHI can be achieved through quaternization and fine-tuning the number of PO units in the polymer structure.
Storr et al.‘s research combined molecular simulation and experimental testing to investigate a zwitterionic kinetic hydrate inhibitor (KHI), namely tributylammonium propyl sulfonate (TBAPS)[
90,
91,
92], as shown in
Figure 10b. They found that TBAPS is slightly more effective than polyvinylpyrrolidone (PVP) in inhibiting hydrate formation. Its unique mechanism of action involves covering rather than directly adhering to the hydrate surface cavities. This mechanistic difference opens up new perspectives for the design and application of hydrate inhibitors. However, molecular simulations in the design phase did not account for interactions between free water and low-dosage hydrate inhibitors (LDHIs), potentially limiting the comprehensive understanding of inhibitor performance. Despite this limitation, molecular simulation technology successfully designed a new product, J3, which significantly outperforms PVCap on the market, particularly in extending the induction period of Type II hydrates, achieving a remarkable effect of over 4000 minutes[
93]. This achievement not only demonstrates the potential of molecular simulation in guiding the development of new hydrate inhibitors but also highlights the application potential of new inhibitors like J3 in enhancing hydrate management efficiency and safety.
In his 2004 study, Huang[
94] investigated the effectiveness of antifreeze proteins (AFPs) as kinetic hydrate inhibitors (KHIs). He found that AFPs effectively inhibit hydrate formation by lowering the freezing point of aqueous solutions through strong interactions[
95,
96,
97,
98,
99,
100,
101,
102,
103]. This process extends the induction time for hydrate formation, slows the conversion rate to methane hydrates, and prevents the reformation of hydrates. This discovery offers a potential method for using natural inhibitors to prevent hydrate formation. Meanwhile, BASF’s patent proposed an innovative approach using graft polymers as gas hydrate inhibitors. These graft polymers, which can be water-soluble or water-dispersible, are optimized by selecting different polymer bases and grafting monomers. Their design combines hydrophilic and hydrophobic components, along with potential biodegradability, to enhance gas hydrate inhibition efficiency and environmental friendliness.